Company Filing History:
Years Active: 2001-2005
Title: Innovations of David Davoudzadeh
Introduction
David Davoudzadeh is an accomplished inventor based in Pleasanton, California. He holds three patents that focus on the detection of ecstasy-class compounds and LSD metabolites in biological samples. His work has significant implications for substance abuse detection and public health.
Latest Patents
One of his notable patents is related to ecstasy-class analogs and their use in the detection of ecstasy-class compounds. This invention provides a system for improved detection of these compounds in biological samples. The new ecstasy-class analogs are designed to construct immunogens and conjugates that generate antibodies capable of distinguishing various ecstasy-class drugs from potentially interfering substances. Another important patent involves an immunoassay for 2-oxo-3-hydroxy LSD, which enhances the detection of LSD and its metabolites in biological samples. This patent utilizes antibodies raised to 2-oxo-3-hydroxy-LSD conjugated to a protein carrier, allowing for accurate detection in samples that may contain interfering substances.
Career Highlights
Throughout his career, Davoudzadeh has worked with reputable companies such as Microgenics Corporation and Microgenetics Corporation. His contributions to the field of drug detection have been recognized for their innovative approach and practical applications.
Collaborations
He has collaborated with notable professionals in the industry, including William A. Coty and Riaz Rouhani. These partnerships have furthered the development of his inventions and enhanced their impact on drug detection methodologies.
Conclusion
David Davoudzadeh's work in the field of drug detection exemplifies innovation and dedication to public health. His patents provide valuable tools for identifying substance abuse, showcasing the importance of scientific advancements in addressing societal challenges.